A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis

BACKGROUND: Renal cell carcinoma (RCC) is one out of the most universal malignant tumors globally, and its incidence is increasing annually. MicroRNA (miRNA) in serum could be considered as a non-invasive detecting biomarker for RCC diagnosis. METHOD: A total of 224 participants (112 RCC patients (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rongkang, Chen, Wenkang, Lu, Chong, Li, Xinji, Chen, Xuan, Huang, Guocheng, Wen, Zhenyu, Li, Hang, Tao, Lingzhi, Hu, Yimin, Zhao, Zhengping, Chen, Zebo, Ni, Liangchao, Lai, Yongqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885090/
https://www.ncbi.nlm.nih.gov/pubmed/36727070
http://dx.doi.org/10.3389/fonc.2022.1076303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885090/
https://www.ncbi.nlm.nih.gov/pubmed/36727070
http://dx.doi.org/10.3389/fonc.2022.1076303

Ejemplares similares